Besides its physiological induction, FGF21 is also elevated in pathological conditions, such as obesity, insulin resistance, or liver diseases, and impairment in FGF21 signaling in these cases has also been also described [43,141,181]. The gene discussed is FGF21; the disease is liver disorder.